Insititut Catala D'Oncologia
199-203 Avinguda de la Granvia
Hospitalet de Llobregat, Barcelona 08908

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma Clinical Trial
A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Status: Enrolling, Phase I
Updated: 12/31/1969
Insititut Catala D'Oncologia
mi
from
Hospitalet de Llobregat,
Click here to add this to my saved trials